STAFF ONLY
  • Español
  • English
Singular-Vega
Infrastructure
Laser VEGA VEGA Calls Laboratories/Workshops Projects FARO. Service Request
Research
& Training
Projects PRTR Projects FEDER Projects Scientific Publications Consolidated Research Unit
Transfer
& Innovation
LITeL Projects Partnership Consulting
Disclosure
& Transparency
DIL2025 Science Bits CLPU Publications Multimedia UCC+i Projects Media Events
Get to Know Us
CLPU
About us Employment website Transparency Portal Contractor profile Electronic Office Contact
STAFF ONLY
HOME •

News • Drug prevents passage of HBV during pregnancy

Drug prevents passage of HBV during pregnancy

1 June 2015

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus, according to a study. Hepatitis B virus, which has infected nearly two billion people worldwide, is a leading cause of liver disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ipBTyidzBQY/150601122546.htm

Return
© CLPU   |   Privacy policy   |   Cookies policy   |   Accesibility   |   Disclaimer   |